检索结果 - Dunphy, Mark

Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET 由 Dunphy, Mark PS., Lewis, Jason S.

获取全文 获取全文 获取全文

The Unique Pharmacometrics of Small Molecule Therapeutic Drug Tracer Imaging for Clinical Oncology 由 Dunphy, Mark P. S., Pillarsetty, Nagavarakishore

获取全文 获取全文 获取全文

Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer 由 Cuaron, John, Dunphy, Mark, Rimner, Andreas

获取全文 获取全文 获取全文

Value of Second Opinion Review of Outside Institution PET-CT examinations 由 Ulaner, Gary A., Mannelli, Lorenzo, Dunphy, Mark

获取全文 获取全文 获取全文

Non-invasive metabolic imaging of brain tumors in the era of precision medicine 由 Kim, Michelle M., Parolia, Abhijit, Dunphy, Mark, Venneti, Sriram

获取全文 获取全文 获取全文

The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature 由 Dunphy, Mark, Pandit-Taskar, Neeta, Fox, Josef J., Kemeny, Nancy

获取全文 获取全文 获取全文

In Vivo Microcartography & Subcellular Imaging of Tumor Angiogenesis: a Novel Platform for Translational Angiogenesis Research 由 Dunphy, Mark P.S., Entenberg, David, Toledo-Crow, Ricardo, Larson, Steven M.

获取全文 获取全文 获取全文

Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation 由 Garcia, Brandon, Goodman, Karyn A., Cambridge, Lajhem, Dunphy, Mark, Wu, Abraham J.

获取全文 获取全文 获取全文

Dosimetry of (18)F-Labeled Tyrosine Kinase Inhibitor SKI-249380, a Dasatinib-Tracer for PET Imaging 由 Dunphy, Mark P. S., Zanzonico, Pat, Veach, Darren, Somwar, Romel, Pillarsetty, Nagavarakishore, Lewis, Jason, Larson, Steven

获取全文 获取全文 获取全文

Specialized second-opinion radiology review of PET/CT examinations for patients with diffuse large B-cell lymphoma impacts patient care and management 由 Sawan, Peter, Rebeiz, Karim, Schoder, Heiko, Batlevi, Connie, Moskowitz, Alison, Ulaner, Gary A., Dunphy, Mark, Mannelli, Lorenzo

获取全文 获取全文 获取全文

Chaperome heterogeneity and its implications for cancer study and treatment 由 Wang, Tai, Rodina, Anna, Dunphy, Mark P., Corben, Adriana, Modi, Shanu, Guzman, Monica L., Gewirth, Daniel T., Chiosis, Gabriela

获取全文 获取全文 获取全文

NIMG-72. PROGNOSTIC VALUE OF [(18)F]-FDG POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH RECURRENT GLIOBLASTOMA RECEIVING BEVACIZUMAB 由 Graham, Maya, Krebs, Simone, Bale, Tejus, Domfe, Kwaku, Lobaugh, Stephanie, Zhang, Zhigang, Dunphy, Mark, Kaley, Thomas, Young, Robert

获取全文 获取全文

Pharmacokinetic Assessment of (18)F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer 由 Grkovski, Milan, Goel, Reema, Krebs, Simone, Staton, Kevin D., Harding, James J., Mellinghoff, Ingo K., Humm, John L., Dunphy, Mark P.S.

获取全文 获取全文 获取全文

Value of [(18)F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab 由 Graham, Maya S, Krebs, Simone, Bale, Tejus, Domfe, Kwaku, Lobaugh, Stephanie M, Zhang, Zhigang, Dunphy, Mark P, Kaley, Thomas, Young, Robert J

获取全文 获取全文 获取全文

High-SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: Supportive evidence to reclassify pleomorphic as non-epithelioid histology 由 Kadota, Kyuichi, Kachala, Stefan S., Nitadori, Jun-ichi, Suzuki, Kei, Dunphy, Mark P. S., Sima, Camelia S., Travis, William D., Rusch, Valerie W., Adusumilli, Prasad S.

获取全文 获取全文 获取全文

Preoperative Consolidation-to-Tumor Ratio and SUVmax Stratify the Risk of Recurrence in Patients Undergoing Limited Resection for Lung Adenocarcinoma ≤2 cm 由 Nitadori, Jun-ichi, Bograd, Adam J., Morales, Eduardo A., Rizk, Nabil P., Dunphy, Mark P. S., Sima, Camelia S., Rusch, Valerie W., Adusumilli, Prasad S.

获取全文 获取全文 获取全文

Detection of Recurrent Pancreatic Cancer: Value of Second-Opinion Interpretations of Cross-Sectional Images by subspecialized radiologists 由 Castellanos, Sandra Huicochea, Corrias, Giuseppe, Ulaner, Gary A., Dunphy, Mark, Zheng Junting, Capanu, Marinela, Balachandran, Vinod, Giancipoli, Romina Grazia, Monti, Serena, Mannelli, Lorenzo

获取全文 获取全文 获取全文

Adaptive neoadjuvant chemotherapy guided by (18)F-FDG-PET in resectable non-small-cell lung cancers: the NEOSCAN trial 由 Chaft, Jamie E., Dunphy, Mark, Naidoo, Jarushka, Travis, William D., Hellmann, Matthew, Woo, Kaitlin, Downey, Robert, Rusch, Valerie, Ginsberg, Michelle S., Azzoli, Christopher G., Kris, Mark G.

获取全文 获取全文 获取全文

FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma 由 Kadota, Kyuichi, Colovos, Christos, Suzuki, Kei, Rizk, Nabil P., Dunphy, Mark P. S., Zabor, Emily C., Sima, Camelia S., Yoshizawa, Akihiko, Travis, William D., Rusch, Valerie W., Adusumilli, Prasad S.

获取全文 获取全文 获取全文

Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71 由 Taldone, Tony, Zatorska, Danuta, Ochiana, Stefan O., Smith-Jones, Peter, Koziorowski, Jacek, Dunphy, Mark P., Zanzonico, Pat, Bolaender, Alexander, Lewis, Jason S., Larson, Steven M., Chiosis, Gabriela, Pillarsetty, Nagavarakishore

获取全文 获取全文 获取全文